Tobacco smoke exposure may diminish the level of clinical benefit provided by ETI after 6 months in patients with cystic fibrosis.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.

Individuals with CF traveling by air may use a COPD preflight assessment to determine whether or not supplemental oxygen is needed during air travel.

Frequent and permanent night shift work is associated with increased lung cancer risk with smoking being a significant factor.

Individuals who have life expectancies less than 3 years may not be appropriate candidates for low-dose CT screening for lung cancer.

Post-thoracentesis ultrasound and chest radiography are equally effective in assessing pleural space evacuation in simple pleural effusions.

Children hospitalized with RSV showed higher risk for ICU admission, IMV, and supplemental oxygen than children hospitalized with COVID-19 or influenza.

The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health care workers alike.

The 2025 World Bronchiectasis Conference highlighted new research on bronchiectasis and NTM - plus an emerging ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.